Rapidly expanding Indian generic drugmaker Lupin has stumbled, having to recall 5 lots of the antibacterial med Suprax (cefixime) because it failed purity tests. The voluntary recall accounts for more than 9,000 bottles but follows a much larger recall of the drug last year. According to the FDA enforcement report, Lupin actually initiated the Class III recall in January after 9-month stability testing found the products didn't meet criteria for total impurities. The Mumbai-based drugmaker told the Economic Times that the voluntary recall was of "no financial consequence." The newspaper says Lupin last year had to recall more than 64,000 bottles. Recall notices here and here. | More | Article